J&J/Legend’s Carvykti Data Show Earlier-Line Efficacy As Commercial Headwinds Remain

 
• By Alaric DeArment
  
J&J/Legend announced positive results from the Phase III CARTITUDE-4 study • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer